Profile: OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

11:43am EDT
Change (% chg)

$-0.05 (-0.83%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

OraSure Technologies, Inc., incorporated on May 5, 2000, is involved in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. These products include tests for the detection of antibodies to the HIV virus, including the OraQuick In-Home HIV Test, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test and the OraSure HIV-1 Oral Specimen Collection Device, a test for antibodies to the HCV virus, the OraQuick HCV Rapid Antibody Test, and oral fluid testing solutions for drugs of abuse testing, including Intercept Oral Fluid Drug Testing System and Q.E.D. Saliva Alcohol Test. The Company also manufactures and sells a range of cryosurgical products. These include Histofreezer, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product for the cryosurgical removal of common and plantar warts. In addition, through its wholly-owned subsidiary DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

Through DNA Genotek Inc., the Company manufactures and sells kits that are used to collect, stabilize, and store samples of genetic material for molecular testing in the consumer genetics, clinical genetic testing, academic research, pharmacogenomics, personalized medicine, and animal genetics markets. The OraGene DNA sample collection kit provides an all-in-one system for the collection, stabilization and transportation of DNA from human saliva. The Company serves customers in many countries worldwide, including many leading research universities and hospitals.

OraQuick Rapid HIV Test

OraQuick is a rapid point-of-care test platform designed to test oral fluid, whole blood (both finger-stick and venous), plasma and serum samples for the presence of various antibodies or analytes. The device uses a porous flat pad to collect an oral fluid specimen. After collection, the pad is inserted into a vial containing a pre-measured amount of developer solution and allowed to develop.

OraQuick In-Home HIV Test

The OraQuick In-Home HIV test is an over-the-counter version of OraQuick ADVANCE HIV ½ Antibody Test. The In-Home Test is performed in the same manner as the OraQuick ADVANCE test, except that it has product labeling and instructions designed for consumers.

OraQuick HCV Rapid Antibody Test

Like the OraQuick HIV test, this product is a qualitative test that can detect antibodies to the Hepatitis C virus, or HCV, in a variety of sample types. The OraQuick HCV test operates in substantially the same manner as the OraQuick HIV tests.

OraSure Collection Device

OraSure oral fluid collection device is used in conjunction with screening and confirmatory tests for HIV-1 antibodies and other analytes. This device consists of a small, treated cotton-fiber pad on a handle that is placed in a person’s mouth for two to five minutes. The device collects oral mucosal transudate, a serum-derived fluid that contains higher concentrations of certain antibodies and analytes than saliva. As a result, OMT testing is a highly accurate method for detecting HIV-1 infection and other analytes.

Company Address

OraSure Technologies Inc

BETHLEHEM   PA   18015
P: +1503.6416115
F: +1610.8821830

Company Web Links

Search Stocks